GlaxoSmithKline CR`s Total Cash From Investing reached -1.83 CZK mil in 2017. This is 74 % less than in the previous year.
Buy Total Cash From Investing data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | -52.0 | -20.0 | -21.0 | 44.7 | -69.9 | |||||||
| Bayer Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||||||
| Merck Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Novartis Czech Republic | CZK mil | -2.94 | -17.3 | -19.9 | -15.1 | -41.3 | |||||||||||||
| Pfizer Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Roche Czech Republic | CZK mil | ... | ... | ... | -65.5 | -159 | -127 | -125 | -114 | ... | |||||||||
| Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | -9.97 | -13.5 | -3.03 | 1.31 | -2.71 | |||||||||
| Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -1.14 | -3.08 | -5.23 | -4.39 | ||
| Walmark | CZK mil | ... | ... | ... | -67.0 | -39.0 | -244 | -71.2 | -441 |
Helgi Library 
